CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Among them, 70 (39.5%) were expressed in PB‐CD34+ and consequently could be aberrantly repressed in CP‐CML CD34+CD15− cells (red dots in Fig. 4; Table S5).